Alpha Casts - AI Market Intelligence
A late-stage AstraZeneca trial miss and Apollo’s caution about a slower AI payoff punctuate a day of mixed corporate beats and governance moves. Investors are parsing strong consumer prints in apparel and petrol windfalls against legal and pipeline risks, while debates intensify over whether to lean risk‑on in growth allocations.
400 afleveringen
Reacties
0Wees de eerste die een reactie plaatst
Meld je nu aan en word lid van de Alpha Casts - AI Market Intelligence community!